Pediatric autoimmune cardiovascular disease.
Pediatric autoimmune cardiovascular disease can cause serious, sometimes life threatening sequelae on the pediatric population. Valvular, myocardial, and pericardial involvement causing morbidity and mortality can occur in association to rheumatic heart disease, systemic lupus erythematosus, and juvenile rheumatoid arthritis. Serious and potentially life threatening coronary artery involvement can occur in patients with childhood polyarteritis nodosa, Takayasu arteritis, and Kawasaki disease.
Rees
A H
AH
Department of Pediatrics, University of Louisville School of Medicine, KY, USA.
D000293:Adolescent; D000974:Antibodies, Antinuclear / Q000097:blood; D001241:Aspirin / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000175:diagnosis* / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D003323:Coronary Aneurysm / Q000175:diagnosis / Q000628:therapy; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D012213:Rheumatic Fever / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D013256:Steroids / Q000627:therapeutic use
D000974:Antibodies, Antinuclear; D016756:Immunoglobulins, Intravenous; D013256:Steroids; D001241:Aspirin